EE04235B1 - Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks - Google Patents

Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks

Info

Publication number
EE04235B1
EE04235B1 EEP200000290A EEP200000290A EE04235B1 EE 04235 B1 EE04235 B1 EE 04235B1 EE P200000290 A EEP200000290 A EE P200000290A EE P200000290 A EEP200000290 A EE P200000290A EE 04235 B1 EE04235 B1 EE 04235B1
Authority
EE
Estonia
Prior art keywords
tetrahydropyridines
alzheimer
namely
treatment
combination
Prior art date
Application number
EEP200000290A
Other languages
English (en)
Estonian (et)
Inventor
Maffrand Jean-Pierre
Soubrie Philippe
Terranova Jean-Paul
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/fr
Priority claimed from FR9714322A external-priority patent/FR2771007B1/fr
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE200000290A publication Critical patent/EE200000290A/xx
Publication of EE04235B1 publication Critical patent/EE04235B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200000290A 1997-11-14 1998-11-09 Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks EE04235B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
FR9714322A FR2771007B1 (fr) 1997-11-14 1997-11-14 Association de principes actifs pour le traitement de la demence senile du type alzheimer
PCT/FR1998/002384 WO1999025363A1 (fr) 1997-11-14 1998-11-09 Association de principes actifs, notamment de tetrahydropyridines et d'agents inhibiteurs de l'acetylcholinesterase, pour le traitement de la demence senile du type alzheimer

Publications (2)

Publication Number Publication Date
EE200000290A EE200000290A (et) 2001-06-15
EE04235B1 true EE04235B1 (et) 2004-02-16

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000290A EE04235B1 (et) 1997-11-14 1998-11-09 Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks

Country Status (27)

Country Link
EP (1) EP1030671A1 (pl)
JP (1) JP2001523642A (pl)
KR (1) KR100599350B1 (pl)
CN (1) CN1243540C (pl)
AU (1) AU743228B2 (pl)
BG (1) BG64819B1 (pl)
BR (1) BR9814035A (pl)
CA (1) CA2309966A1 (pl)
CO (1) CO4980891A1 (pl)
DZ (1) DZ2649A1 (pl)
EA (1) EA003255B1 (pl)
EE (1) EE04235B1 (pl)
HU (1) HUP0100098A3 (pl)
ID (1) ID24933A (pl)
IL (2) IL136122A0 (pl)
IS (1) IS5482A (pl)
MY (1) MY120461A (pl)
NO (1) NO20002450L (pl)
NZ (1) NZ504420A (pl)
OA (1) OA11464A (pl)
PL (1) PL194597B1 (pl)
SA (1) SA98190747B1 (pl)
SK (1) SK286040B6 (pl)
TR (1) TR200001262T2 (pl)
TW (1) TW585766B (pl)
UY (1) UY25247A1 (pl)
WO (1) WO1999025363A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1514542T1 (sl) 2002-06-14 2012-06-29 Toyama Chemical Co Ltd Farmacevtska sestava, vsebujoäśa takrin ali donepezil za izboljĺ anje moĺ˝ganske funkcije
ES2327914T3 (es) * 2002-08-07 2009-11-05 Novartis Ag Metodo para pronosticar la sensibilidad al tratamiento con ravastigmina basado en el genotipo apoe de pacintes con demencia.
CN1520818A (zh) * 2003-02-09 2004-08-18 ɽ����Ҷ��Ȼҩ���о��������޹�˾ 治疗老年性痴呆的胆碱酯酶抑制剂药物组合物
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
DK3099296T3 (en) 2014-01-31 2019-04-15 Cognition Therapeutics Inc ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
EP3634394B1 (en) * 2017-05-15 2025-12-24 Cognition Therapeutics, Inc. Compositions for treating neurodegenerative diseases
WO2019182319A1 (ko) * 2018-03-20 2019-09-26 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
KR102224917B1 (ko) 2018-03-20 2021-03-09 (주)인벤티지랩 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물의 제조 방법 및 이의 제조 방법으로 제조된 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물
CN109265391B (zh) * 2018-11-13 2021-11-19 枣庄学院 联苯多取代1,2,5,6-四氢吡啶化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
PT813416E (pt) * 1995-03-06 2005-10-31 Interneuron Pharma Reducao do volume de enfarte usando citicolina
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines

Also Published As

Publication number Publication date
IL136122A0 (en) 2001-05-20
PL194597B1 (pl) 2007-06-29
AU743228B2 (en) 2002-01-24
HUP0100098A2 (hu) 2001-07-30
EE200000290A (et) 2001-06-15
WO1999025363A1 (fr) 1999-05-27
IS5482A (is) 2000-05-09
OA11464A (en) 2003-11-18
HUP0100098A3 (en) 2001-12-28
CN1285742A (zh) 2001-02-28
JP2001523642A (ja) 2001-11-27
SK286040B6 (sk) 2008-01-07
KR20010032099A (ko) 2001-04-16
TR200001262T2 (tr) 2001-01-22
AU1160999A (en) 1999-06-07
NZ504420A (en) 2003-08-29
SK7112000A3 (en) 2000-10-09
CN1243540C (zh) 2006-03-01
KR100599350B1 (ko) 2006-07-12
SA98190747B1 (ar) 2006-11-04
UY25247A1 (es) 2001-05-31
IL136122A (en) 2006-07-05
MY120461A (en) 2005-10-31
CA2309966A1 (en) 1999-05-27
TW585766B (en) 2004-05-01
BR9814035A (pt) 2000-09-26
EA003255B1 (ru) 2003-02-27
NO20002450D0 (no) 2000-05-11
CO4980891A1 (es) 2000-11-27
BG64819B1 (bg) 2006-05-31
DZ2649A1 (fr) 2004-12-28
EA200000412A1 (ru) 2000-12-25
BG104428A (en) 2001-08-31
PL340500A1 (en) 2001-02-12
EP1030671A1 (fr) 2000-08-30
ID24933A (id) 2000-08-31
NO20002450L (no) 2000-07-14

Similar Documents

Publication Publication Date Title
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60022867D1 (de) 1-Arenesulfonyl-2-Aryl-Pyrrolidin und Piperidin Derivative zur Behandlung von CNS-Erkrankungen
AU5716898A (en) Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
NO20001869L (no) FremgangsmÕte for behandling av Alzheimers sykdom
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
EE200000290A (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
AU3364499A (en) Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
DE69838785D1 (de) Pharmazeutische mittel zur behandlung von zerebralen amyloidosis
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
ATE234617T1 (de) Verwendung des saredutant und seiner pharmazeutisch akzeptablen salze zur behandlung von schwere depression
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
NO991800L (no) FremgangsmÕte ved fremstilling av 2-azadihydroksybicyklo [2.2.2]-heptanforbindelser samt L-tartarsyresalter av forbindelsene
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
GR3033316T3 (en) Substituted 4-(6-fluoro-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
NO981499L (no) FremgangsmÕte for fremstilling av titandioksyd
KR100248098B1 (en) Pharmaceutical composition for the treatment of dementia
NO20014026L (no) Krampestillende derivater til behandling av betydelig skjelving
FR2718027B1 (fr) Produit destiné au traitement et à la prévention des alopécies.
HUP0202145A3 (en) The use of r(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type

Legal Events

Date Code Title Description
HD1A Correction of address
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081109